Peptide-drug Conjugate Information

General Information of This Peptide-drug Conjugate (PDC)
PDC ID
PDC_00094
PDC Name
Cq-S-S-TP10
PDC Status
Investigative
Indication
In total 1 Indication(s)
Malaria
Structure
Peptide Name
TP10
  Peptide Info 
Drug Name
N1-(7-chloroquinolin-4-yl)butane-1,4-diamine
  Drug Info 
Linker Name
Cystine
  Linker Info 
Formula
C123H209ClN32O25S2
#Ro5 Violations (Lipinski): 4 Molecular Weight 2635.811
Lipid-water partition coefficient (xlogp) -1.0306
Hydrogen Bond Donor Count (hbonddonor) 32
Hydrogen Bond Acceptor Count (hbondacc) 35
Rotatable Bond Count (rotbonds) 96
Full List of Activity Data of This Peptide-drug Conjugate
Obtained from the Model Organism Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Data of This PDC [1]
Indication Malaria
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
1.0 ± 0.3 µM
MOA of PDC
The significant increase in the hemolytic activity of TP10 upon conjugation to the 4-aminoquinoline suggests that drug cargo prevents an otherwise active CPP carrier from exerting the desired cell penetrating/antiplasmodial action safely, as it produces conjugates that exert membranolytic activity.
In Vivo Model Plasmodium falciparum 3D7.
References
Ref 1 Coupling the Antimalarial Cell Penetrating Peptide TP10 to Classical Antimalarial Drugs Primaquine and Chloroquine Produces Strongly Hemolytic Conjugates. Molecules. 2019 Dec 12;24(24):4559. doi: 10.3390/molecules24244559.